about
Macrophage ABCA5 deficiency influences cellular cholesterol efflux and increases susceptibility to atherosclerosis in female LDLr knockout miceRegulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion developmentUSF1 deficiency activates brown adipose tissue and improves cardiometabolic healthThe liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in miceDiet induced regulation of genes involved in cholesterol metabolism in rat liver parenchymal and Kupffer cellsEffects of deletion of macrophage ABCA7 on lipid metabolism and the development of atherosclerosis in the presence and absence of ABCA1Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoECyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway.ATP-binding cassette transporter A1 in lipoprotein metabolism and atherosclerosis: a new piece of the complex puzzle.Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol.Scavenger receptor BI: a multi-purpose player in cholesterol and steroid metabolismGenetic studies in mice and humans reveal new physiological roles for the high-density lipoprotein receptor scavenger receptor class B type I.Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice.Leukocyte ABCA1 remains atheroprotective in splenectomized LDL receptor knockout miceMacrophage adipose triglyceride lipase deficiency attenuates atherosclerotic lesion development in low-density lipoprotein receptor knockout miceAbsence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting.Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development.Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout miceHaloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout miceHigh-density lipoprotein attenuates Th1 and th17 autoimmune responses by modulating dendritic cell maturation and function.Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis.Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?LCAT deficiency in mice is associated with a diminished adrenal glucocorticoid function.HDL is redundant for adrenal steroidogenesis in LDLR knockout mice with a human-like lipoprotein profile.Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production.High-density lipoprotein: key molecule in cholesterol efflux and the prevention of atherosclerosis.Relative roles of various efflux pathways in net cholesterol efflux from macrophage foam cells in atherosclerotic lesions.ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.High-density lipoprotein as a modulator of platelet and coagulation responses.ATP-binding cassette transporter A1: key player in cardiovascular and metabolic disease at local and systemic level.Mouse models of disturbed HDL metabolism.Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation.HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.Simvastatin treatment aggravates the glucocorticoid insufficiency associated with hypocholesterolemia in mice.Human ATP-binding cassette G1 controls macrophage lipoprotein lipase bioavailability and promotes foam cell formation.High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling.Plasma lipoproteins are required for both basal and stress-induced adrenal glucocorticoid synthesis and protection against endotoxemia in mice.Adrenocortical LDL receptor function negatively influences glucocorticoid output.
P50
Q24306389-681AD185-76CB-4A4B-AAC1-3C5DC86BF525Q28260242-0D5B5040-E6A4-4B05-8A0F-5F2C880D6655Q28272648-FFE316B8-D987-4A01-AE20-0FC23FFE4042Q28472536-F9E3423E-09B6-4CD0-9FC2-EAA224D46A85Q28572522-3ED668CD-FB7A-4076-B5EC-A0D2CA103E7DQ28731534-E9A9C92B-66AA-4FDD-A8C1-239453E9C088Q28744040-7D6801F7-F7B1-414C-91E8-DB310D08984EQ30491848-015DB26B-EB18-43D4-9A52-E840E49C61E6Q33356513-86FC7621-DF7B-4441-A7B2-8176A791A099Q33389359-CC3807DA-377C-4850-9D89-310F48B0F265Q33392687-0C9C1752-5F04-464A-8F9F-9CE094C851F7Q33393289-E45A7260-5CE1-4F4E-A540-05F2DFC0FCCDQ33399268-89129C8F-5B76-4EBA-A1F7-D9901A72AC19Q34407326-158B5ECB-4C06-4DD6-AA7B-AC03888E7449Q34469315-15EE925E-3883-4D9B-9C3F-A15005E10757Q34717864-05F15AEC-B17C-4A93-B106-F873268D075EQ34737784-A517DA7C-97C4-4ED2-9E0B-C8BBC4FCC48FQ35103176-B86B987F-85DD-4298-BEAF-9F35AE08EAA5Q35167972-1F512076-6868-4EEA-B989-11E8A7D55F19Q35484483-6675574C-1629-43EE-AAC2-7D6C17B9D18EQ35562936-FD19D26F-8DCD-4FDA-BF7E-31CFCDF5FCBEQ36125671-347BB612-6A59-4F6D-8C15-EEF888F0CEAEQ36145188-90DCE791-71D4-4694-BBF0-F770821AF22AQ36658359-8408E2FD-878E-4108-99EC-DBA78067C5DCQ36731763-85647D4B-D086-4ECF-BF0A-B26F3D66E594Q37190356-01D267CB-7E43-4DD5-889D-A54938001ACEQ37701872-63BFD52A-598B-4226-A78A-2A2E22BC7982Q37777603-6E84D7B9-93D9-4E62-B7FA-56736375599DQ37805532-314F8188-81F6-41A2-BA1D-C54F194297B3Q38217201-5D54C76A-2E97-4993-9233-15FC3F2BC62AQ38225960-B031E748-158B-4112-A9FD-3DACBDC28256Q38293457-CE65FE57-184F-4F0F-913E-835E447E9176Q38300972-94D972CD-6B3D-48B6-917D-816D5430DB12Q38627278-4A4A391C-8ED8-4AC5-BC8F-504A87B1A5F0Q38919871-7D51A2BF-6EBB-463A-AD59-8FFDDA2CCB2AQ38939154-A0B99EF4-17C8-402E-895E-5E16546C0D2BQ39318056-06E56D5E-0FD1-4F71-8DA3-5705D0A1738FQ40443577-5606E6F5-0ACD-43CE-BE2E-0CE77CF66400Q42477363-49B55690-314A-472C-AB89-4904FBAAE8AAQ42479217-52B8A7C9-22D9-446A-872A-AB4F4520ACE2
P50
subject
description
Forscher
@de
chercheur
@fr
hulumtuese
@sq
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Miranda Van Eck
@ast
Miranda Van Eck
@en
Miranda Van Eck
@es
Miranda Van Eck
@nl
type
label
Miranda Van Eck
@ast
Miranda Van Eck
@en
Miranda Van Eck
@es
Miranda Van Eck
@nl
prefLabel
Miranda Van Eck
@ast
Miranda Van Eck
@en
Miranda Van Eck
@es
Miranda Van Eck
@nl
P1006
P1006
P106
P21
P31
P496
0000-0003-3936-3194